Engineering tumoral vascular leakiness with gold nanoparticles

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapeutics

Background:

• Effective delivery of cancer therapeutics to tumors is hindered by insufficient vascular permeability.
• Tumor vasculature often lacks the necessary leakiness for drugs to penetrate effectively.

Purpose of the Study:

• To engineer enhanced vascular leakiness in tumors using nanoparticles to improve drug delivery.
• To assess the efficacy of nanoparticle-induced vascular leakiness in facilitating therapeutic infiltration and cancer regression.

Main Methods:

• Development of gold nanoparticles engineered to induce endothelial leakiness (NanoEL).
• In vivo studies using real-time intravital imaging to observe nanoparticle effects on tumor vasculature.
• Evaluation of therapeutic efficacy in primary tumor and micrometastasis animal models after NanoEL pretreatment.

Main Results:

• NanoEL gold nanoparticles induced endothelial leakiness by affecting adherens junctions without cellular toxicity.
• Intravital imaging confirmed NanoEL particles increased tumor vessel permeability and interstitial space infiltration.
• Pretreatment with NanoEL particles led to complete regression of primary tumors and micrometastases.

Conclusions:

• Engineering tumoral vasculature leakiness is a novel strategy to enhance anti-cancer therapeutic accessibility.
• NanoEL nanoparticles offer a promising approach to overcome drug delivery barriers in cancer treatment.
• This method represents a paradigm shift, focusing on improving drug delivery rather than solely increasing drug potency.